Basilea Pharmaceutica AG (BPMUF)
OTCMKTS
· Delayed Price · Currency is USD
57.70
0.00 (0.00%)
At close: Jun 6, 2025
Basilea Pharmaceutica AG Employees
Basilea Pharmaceutica AG had 164 employees as of December 31, 2024. The number of employees increased by 17 or 11.56% compared to the previous year.
Employees
164
Change (1Y)
17
Growth (1Y)
11.56%
Revenue / Employee
$1,403,257
Profits / Employee
$522,113
Market Cap
753.83M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Tian'an Technology Group | 8 |
CytoDyn | 9 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Basilea Pharmaceutica AG News
- 5 weeks ago - Assessment of the 14-Alpha Demethylase Inhibitors Pipeline Landscape 2025, Featuring Insights Into Oteseconazole (Mycovia Pharmaceuticals) and Isavuconazonium (Basilea Pharmaceutica) - GlobeNewsWire
- 7 weeks ago - Strong sales for Cresemba® (isavuconazole) in Japan trigger second milestone payment from Asahi Kasei Pharma to Basilea - GlobeNewsWire
- 4 months ago - Basilea Pharmaceutica Ltd (XSWX:BSLN) Full Year 2024 Earnings Call Highlights: A Year of Robust ... - GuruFocus
- 4 months ago - Full Year 2024 Basilea Pharmaceutica AG Allschwil Earnings Call Transcript - GuruFocus
- 4 months ago - Basilea projects CHF220M in 2025 revenue with key pipeline advancements and U.S. launch of Zevtera - Seeking Alpha
- 4 months ago - Basilea Pharmaceutica AG (BPMUF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Basilea Pharmaceutica AG 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 4 months ago - Basilea Pharmaceutica GAAP EPS of CHF5.83, revenue of CHF208.5M; initiates FY25 outlook - Seeking Alpha